Jun 25, 2005
A client recently asked me if I had heard anything about the FDA approval process of Timpanivir. I have been checking every source I can think of and have not been able to find any information. DO you have any current information about the approval process and when this medication may become available?
| Response from Dr. Young
Tipranavir (APTIVUS), a new generation protease inhibitor was approved by the US FDA this week. The drug will be used for very treatment-experienced patients with PI resistance and requires 200 mg of ritonavir, twice daily.
Stay tuned for more information. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.